Literature DB >> 8723370

Epidemiological study on insomnia in the general population.

M Ohayon1.   

Abstract

This study was conducted with a representative sample of the French population of 5,622 subjects of 15 years old or more. The telephone interviews were performed with EVAL, an expert system specialized for the evaluation of sleep disorders. From this sample, 20.1% of persons said that they were unsatisfied with their sleep or taking medication for sleeping difficulties or anxiety with sleeping difficulties (UQS). A low family income, being a woman, being over 65 years of age, being retired and being separated, divorced or widowed are significantly associated with the presence of UQS. A sleep onset period over 15 minutes, a short night's sleep and regular nighttime awakenings are also associated with UQS. Medical consultations during the past 6 months and physical illnesses are more frequent among the UQS group. The consumption of sleep-enhancing medication and medication to reduce anxiety is important: in the past, 16% of subjects had taken a sleep-enhancing medication and 16.2% a medication to reduce anxiety. At the time of the survey 9.9% of the population were using sleep-enhancing medication and 6.7% were using medication for anxiety. For most, hypnotic consumption was long-term: 81.6% had been using it for more than 6 months.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8723370     DOI: 10.1093/sleep/19.suppl_3.s7

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  74 in total

1.  A general model of the effects of sleep medications on the risk and cost of motor vehicle accidents and its application to France.

Authors:  J Menzin; K M Lang; P Levy; E Levy
Journal:  Pharmacoeconomics       Date:  2001-01       Impact factor: 4.981

2.  Sleep disturbance and kynurenine metabolism in depression.

Authors:  Hyong Jin Cho; Jonathan Savitz; Robert Dantzer; T Kent Teague; Wayne C Drevets; Michael R Irwin
Journal:  J Psychosom Res       Date:  2017-05-22       Impact factor: 3.006

Review 3.  Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment.

Authors:  M V Vitiello; S Borson
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  Prevalence, course, and comorbidity of insomnia and depression in young adults.

Authors:  Daniel J Buysse; Jules Angst; Alex Gamma; Vladeta Ajdacic; Dominique Eich; Wulf Rössler
Journal:  Sleep       Date:  2008-04       Impact factor: 5.849

5.  A warm footbath before bedtime and sleep in older Taiwanese with sleep disturbance.

Authors:  Wen-Chun Liao; Ming-Jang Chiu; Carol A Landis
Journal:  Res Nurs Health       Date:  2008-10       Impact factor: 2.228

6.  [Disturbances of slow-wave sleep and psychiatric disorders].

Authors:  J P Doerr; V Hirscher; D Riemann; U Voderholzer
Journal:  Nervenarzt       Date:  2010-03       Impact factor: 1.214

7.  Is insomnia a perpetuating factor for late-life depression in the IMPACT cohort?

Authors:  Wilfred R Pigeon; Mark Hegel; Jürgen Unützer; Ming-Yu Fan; Michael J Sateia; Jeffrey M Lyness; Cindy Phillips; Michael L Perlis
Journal:  Sleep       Date:  2008-04       Impact factor: 5.849

8.  A community-based cross-sectional study of sleep quality in middle-aged and older adults.

Authors:  Hui-Shan Zhang; Yuan Li; Hai-Yun Mo; De-Xing Qiu; Jing Zhao; Jia-Li Luo; Wei-Quan Lin; Jia-Ji Wang; Pei-Xi Wang
Journal:  Qual Life Res       Date:  2016-09-12       Impact factor: 4.147

9.  Epidemiology of insomnia in korean adults: prevalence and associated factors.

Authors:  Yong Won Cho; Won Chul Shin; Chang Ho Yun; Seung Bong Hong; Juhan Kim; Christopher J Earley
Journal:  J Clin Neurol       Date:  2009-03-31       Impact factor: 3.077

10.  Sociodemographic profile of insomniac patients across national surveys.

Authors:  François-André Allaert; Renaud Urbinelli
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.